ClearPoint Neuro(CLPT) - 2023 Q1 - Quarterly Report

FORM 10-Q Commission file number: 001-34822 Securities registered pursuant to Section 12(b) of the Act: Large accelerated filer o Accelerated filer ☐ Non-accelerated filer þ Smaller reporting company þ Emerging growth company o TABLE OF CONTENTS This Quarterly Report contains "forward-looking statements" as defined under the United States federal securities laws. The forwardlooking statements relate to our expectations for performance, revenues and costs, and the adequacy of cash and cash equivalent balance ...